CMA1 and rosacea: These data provide evidence that ssON treatment is able to dampen the upregulation of Tpsab1, Mmp9, and Cma1 in murine skin induced by LL-37 and subsequently reduces the LL-37-mediated inflammation in a murine model of rosacea.